array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "ROCHE DIAGNOSTICS LIMITED" ["slug"]=> string(34) "ef866-gb-roche-diagnostics-limited" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c" ["description"]=> string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com/global/en Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation" ["address_street"]=> string(14) "Charles Avenue" ["address_place"]=> string(12) "BURGESS HILL" ["address_region"]=> NULL ["founding_date"]=> string(10) "1956-09-14" ["website_domain"]=> string(9) "roche.com" ["website_url"]=> string(29) "https://diagnostics.roche.com" ["industry_codes"]=> array(1) { [0]=> string(43) "Business Services, Not Elsewhere Classified" } ["employee_count"]=> int(658) ["article_count"]=> int(3438) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(19) "Tao Huo Zhuan "New"" ["snippet_en"]=> string(100) "Novel Clinic Assets OÜ has filed a lawsuit against Hepsor P113 OÜ, an affiliate of Hepsor AS.Novel" ["url"]=> string(116) "https://portal.sina.com.hk/news-china/sina/2023/12/14/669745/%E9%99%B6%E7%81%AB%E5%82%B3%E3%80%8C%E6%96%B0%E3%80%8D/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d29cafa4-99f6-43cf-93df-c0ea6a063fa8" ["source"]=> string(11) "sina.com.hk" ["publication_date"]=> string(10) "2023-12-14" ["categories"]=> array(4) { [0]=> string(22) "Sustainable Investment" [1]=> string(10) "Litigation" [2]=> string(5) "Legal" [3]=> string(19) "Green & Responsible" } } [1]=> array(7) { ["title_en"]=> string(56) "Roche sues Intas Pharma over Mircera anaemia drug patent" ["snippet_en"]=> string(167) "Swiss biotechnology giant Roche has sued Ahmedabad-based drug maker Intas Pharmaceuticals in Delhi High Court, alleging infringement of its patent rights over Mircera." ["url"]=> string(162) "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/roche-sues-intas-pharma-over-mircera-anaemia-drug-patent/articleshow/51874998.cms" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8b5131be-d3e4-44e3-a629-930a7e06cc20" ["source"]=> string(14) "indiatimes.com" ["publication_date"]=> string(10) "2023-11-06" ["categories"]=> array(6) { [0]=> string(21) "Intellectual Property" [1]=> string(26) "Product Quality and safety" [2]=> string(8) "Verdicts" [3]=> string(10) "Litigation" [4]=> string(5) "Legal" [5]=> string(17) "Business Disputes" } } [2]=> array(7) { ["title_en"]=> string(78) "Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug" ["snippet_en"]=> string(246) "Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roche's blockbuster rheumatoid arthritis drug Actemra, according to a filing on Monday in Massachusetts federal court." ["url"]=> string(23) "https://reut.rs/45Yy8S5" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0b40abce-1f71-41a1-8ce5-18aaed6e2510" ["source"]=> string(7) "reut.rs" ["publication_date"]=> string(10) "2023-10-23" ["categories"]=> array(10) { [0]=> string(27) "Business Model & Innovation" [1]=> string(21) "Intellectual Property" [2]=> string(20) "Conflict of Interest" [3]=> string(8) "Verdicts" [4]=> string(10) "Litigation" [5]=> string(15) "Business Ethics" [6]=> string(5) "Legal" [7]=> string(16) "Case Settlements" [8]=> string(21) "Competitive Behaviour" [9]=> string(46) "Management of Legal and Regulatory Environment" } } [3]=> array(7) { ["title_en"]=> string(68) "Roche scores—again—in hemophilia drug patent case against Takeda" ["snippet_en"]=> string(249) "In a patent case centered on two rival hemophilia medicines, Roche's Genentech unit has scored its second straight win. | After Takeda's Baxalta unit moved to appeal a prior loss, the U.S. federal appeals court backed the decision in favor of Roche." ["url"]=> string(108) "https://www.fiercepharma.com/pharma/appeals-court-backs-roches-hemlibra-patent-case-against-takeda-subsidary" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d217ffa8-8536-4f03-9d29-ad6260109f60" ["source"]=> string(16) "fiercepharma.com" ["publication_date"]=> string(10) "2023-09-21" ["categories"]=> array(4) { [0]=> string(10) "Litigation" [1]=> string(21) "Intellectual Property" [2]=> string(5) "Legal" [3]=> string(8) "Verdicts" } } [4]=> array(7) { ["title_en"]=> string(74) "US court upholds Roche win in patent case over blockbuster hemophilia drug" ["snippet_en"]=> string(211) "Roche subsidiary Genentech convinced a U.S. appeals court on Wednesday to affirm that its blockbuster hemophilia treatment Hemlibra does not infringe a patent owned by pharmaceutical rival Takeda's Baxalta unit." ["url"]=> string(124) "https://www.reuters.com/legal/litigation/us-court-upholds-roche-win-patent-case-over-blockbuster-hemophilia-drug-2023-09-20/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/aa9f8105-8c99-4a34-b42c-91b0581cc40d" ["source"]=> string(11) "reuters.com" ["publication_date"]=> string(10) "2023-09-20" ["categories"]=> array(8) { [0]=> string(27) "Business Model & Innovation" [1]=> string(21) "Intellectual Property" [2]=> string(8) "Verdicts" [3]=> string(10) "Litigation" [4]=> string(5) "Legal" [5]=> string(46) "Management of Legal and Regulatory Environment" [6]=> string(16) "Case Settlements" [7]=> string(21) "Competitive Behaviour" } } [5]=> array(7) { ["title_en"]=> string(55) "Roche sues Novartis unit over generic lung disease drug" ["snippet_en"]=> string(273) "Swiss drugmaker Roche's Genentech [RIC:RIC:ROGING.UL] subsidiary has accused a Novartis unit of infringing one of its patents by selling a generic version of its blockbuster lung disease drug Esbriet, after an earlier lawsuit failed to keep the generic drug off the market." ["url"]=> string(108) "https://www.reuters.com/legal/litigation/roche-sues-novartis-unit-over-generic-lung-disease-drug-2023-08-01/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f50b1982-1a0d-43cc-ac6a-996e798aec38" ["source"]=> string(11) "reuters.com" ["publication_date"]=> string(10) "2023-08-01" ["categories"]=> array(3) { [0]=> string(11) "Competition" [1]=> string(10) "Litigation" [2]=> string(5) "Legal" } } [6]=> array(7) { ["title_en"]=> string(50) "Roche sues Novartis over generic lung disease drug" ["snippet_en"]=> string(169) "The Genentech subsidiary of the Swiss pharmaceutical company Roche is taking action in the USA against a generic of its lung drug Esbriet from the manufacturer Novartis." ["url"]=> string(102) "https://www.cash.ch/news/top-news/roche-verklagt-novartis-wegen-generikum-gegen-lungenkrankheit-624804" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c796b51b-7065-4369-9a0b-dae8c37d17a1" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2023-08-01" ["categories"]=> array(2) { [0]=> string(10) "Litigation" [1]=> string(5) "Legal" } } [7]=> array(7) { ["title_en"]=> string(63) "Roche sues Biogen over biosimilar of blockbuster arthritis drug" ["snippet_en"]=> string(240) "Roche and two of its subsidiaries sued biotech company Biogen in Massachusetts federal court on Thursday, accusing its proposed similar version of Roche's blockbuster rheumatoid arthritis drug Actemra of infringing several of their patents." ["url"]=> string(95) "https://www.nasdaq.com/articles/roche-sues-biogen-over-biosimilar-of-blockbuster-arthritis-drug" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-07-14" ["categories"]=> array(2) { [0]=> string(10) "Litigation" [1]=> string(5) "Legal" } } [8]=> array(7) { ["title_en"]=> string(48) "Roche is suing Biogen in the US over biosimilars" ["snippet_en"]=> string(44) "allegations of multiple patent infringements" ["url"]=> string(62) "https://www.trend.at/news/roche-biogen-usa-biosimilar-13093344" ["image_url"]=> string(78) "https://images.businessradar.com/articles/639049df-2225-4282-be85-36441b23e50c" ["source"]=> string(8) "trend.at" ["publication_date"]=> string(10) "2023-07-14" ["categories"]=> array(2) { [0]=> string(10) "Litigation" [1]=> string(18) "China-US Relations" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(217) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(204) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(192) } [3]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(156) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(153) } [5]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(148) } [6]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(137) } [7]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(136) } [8]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(111) } [9]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(105) } [10]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(102) } [11]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(97) } [12]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(92) } [13]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(89) } [14]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(86) } [15]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(69) } [16]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(65) } [17]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(64) } [18]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(63) } [19]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(49) } [20]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(42) } [21]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(40) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(40) } [23]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(38) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(33) } [25]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(33) } [26]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(32) } [27]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(32) } [28]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(32) } [29]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(32) } } } ef866-gb-roche-diagnostics-limited